Comparable Progression Risk Seen With Ablation Versus Surgery for T1a Renal Cell Carcinoma

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Amazon Big Spring Sale - Up to 40% off

Medically reviewed by Drugs.com

via HealthDay

WEDNESDAY, March 4, 2026 -- For patients with stage T1a renal cell carcinoma (T1a RCC), ablation seems to be as effective as resection or nephrectomy, according to a study published online March 3 in Radiology.

Johanne Ahrenfeldt, Ph.D., from Aarhus University Hospital in Denmark, and colleagues conducted a nationwide-registry cohort study involving Danish adults diagnosed with T1a RCC between January 2013 and December 2021 to compare patients treated with tumor ablation, surgical resection, or nephrectomy. The study included 1,862 patients (median age, 64 years).

The researchers found that after adjustment for confounders, there was no evidence of a difference in progression risk between the ablation and resection groups. Local recurrence occurred most often following ablation (2.41 percent compared with 1.20 and 0 percent for resection and nephrectomy, respectively); with additional procedures, local recurrence was treatable. Distant metastasis occurred most often after nephrectomy, followed by resection and ablation (4.38 versus 1.90 and 1.67 percent, respectively). The shortest hospital stays were seen for ablation (median of zero days compared with two days each for resection and nephrectomy). The fewest 30-day posttreatment hospital contacts resulted from ablation versus resection and nephrectomy, suggesting fewer complications with ablation.

"Although the local recurrence rate was slightly higher in the ablation group, tumors that recur can be successfully treated with another ablation or surgery," lead author Iben Lyskjær, Ph.D., also from Aarhus University, said in a statement. "Importantly, patients in the study who had local recurrences did not have worse overall survival."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-05 08:48

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords